Cardiac Science v. Philips Medical
This article was originally published in The Gray Sheet
Executive Summary
Automated external defibrillator patent suit filed Feb. 12 in Minnesota federal court alleges Philips' HeartStart AEDs infringe seven Cardiac Science patents related to the Powerheart AED. The suit follows Cardiac Science's successful litigation of AED maker Zoll last year, which involved one of the same patents for electrode packaging and ended in a settlement with a cross-license and payment of royalties...
You may also be interested in...
Cardiac Science v. Defibtech
Powerheart automatic public-access defibrillator manufacturer announces Aug. 9 it will receive a cash payment of $925,000 in its settlement of a patent dispute with Defibtech. Cardiac Science brought the patent infringement claims against Defibtech in April 2003. Cardiac Science also plans to continue with outstanding patent litigation that it brought against Philips in early 2003 (1"The Gray Sheet" Feb. 17, 2003, In Brief)...
Philips Medical v. Cardiac Science
Philips Electronics' June patent infringement suit against Cardiac Science is dismissed by Seattle district court Sept. 3. Court determines Cardiac Science's patent suit filed against Philips in Minnesota on Feb. 12 takes priority over the Washington case, according to Cardiac Science. The suits relate to 10 U.S. patents for Cardiac Science's Powerheart automated external defibrillator (1"The Gray Sheet" Feb. 17, 2003, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.